Come on and get real. Roche got Xenical approved in Europe and is selling it there. There isn't a more dangerous or sleazier drug on the market than that!
I think Roche didn't want to put up as much as AENA wanted so Eisai stepped in and put up the upfront money and Roche will walk this through EMA and co-market for part of the split. That's why they had to lower Arena's share. Roche & Eisai have a collaboration going already: CAMBRIDGE, Mass., Jan. 7, 2013 /PRNewswire/ -- Epizyme, Inc., a biopharmaceutical company leading the creation of personalized therapeutics to treat patients with genetically defined cancers, Eisai Co., Ltd. (ESALY) and Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a collaboration to develop an in vitro PCR (Polymerase Chain Reaction) based companion diagnostic test. The collaboration's goal is to identify lymphoma patients with non-wild type EZH2, including the Y641 mutation. As demonstrated in Epizyme's Nature Chemical Biology publication, "A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells [link]," lymphomas with genetic alterations of EZH2 require EZH2 enzymatic activity for proliferation, suggesting that EZH2 is a driving oncogene in these cancers and therefore an important therapeutic target
There is no doubt AF and CS analyst and possibly others will come out swinging. There are many shorts trapped here and the Street and their thugs are the biggest liars and crooks in America (along with Obama and Democrats). They ain't about to go away easy.
Chantix generated $720 million in sales last year for Pfizer At that level Ratio becomes .365 and translates into $262.8 million to Arena plus milestones of $95.5 million for annual total revenue of $358.3 million or Earnings of .71 a share X18(biotech PE) = $12.75 a share. It would be just fine if it sells like Chantix.
Hedge is going to be wiped out tomorrow - he put on a huge option put trade and can't get out afterhours. He's sitting there quaking in his boots. I tried to warn him but he thought he knew more than everyone else. I always like seeing a pompous a-whole getting burned.
Also you left out Xenical, with over $500 million in annual sales about to be pulled from market. Also you left out Bel Phen.
You left out Euro partner being announced, you left out 1,000 doctors giving lectures. You left out increase in sales force, some have already hit the field. You left out insurance just went to 40% and headed to 50% by year end (per Eisai CC). You left out 10,000 doctors now scripting. You left out DTC advertising just started and TV about to start. You left out Mexico approval about to be announced with Korea and Taiwan right behind. You left out $112 million in milestones and collaborations coming. You left out their other drugs are now at point a partner and upfront payments could be announced at any moment. You left out the bill in Congress.
There have been some rumors of a Roche buyout but that isn't what's likely. Roche is going to buy the marketing rights to Europe for an upfront payment of $50-$100 million (ARNA will keep this even if not approved) plus milestone payments upon and after approval, plus 38-42% royalties on every sale. It's a very cheap way for them to replace Xenical in Europe as opposed to spending $1.2 billion to develop a drug that may or may not make it through Phase 3.
Roche took the obesity drug Xenical through EMA approval so they have the expertise to get Belviq approved.
Yes, Belviq is perfect for Roche because they are also going to see Xenical taken off market and need Belviq to replace it.
Yhey have been talking all year. Announcement could come tomorrow: A Fly On The Wall_ Roche And Arena Pharmaceuticals (ARNA) Conference Call_Partnership In EU With EMA Belviq Approval Topic Projects Biotech News Stock biotechnewsstockreview.blogspotdotcom/a-fly-on-walleisai-roche-and-arena.
No, it is not the same as debt from an investor perspective. Most debt that public corporations carry does not amortize out and needs to be refinanced, often involving dilution of the stock. This does not need to be refinanced and goes out until 2027.